Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019

被引:0
|
作者
Hee Soo Kim
Yongho Oh
Joanna Korejwo
Valérie Bosch Castells
Kuhyun Yang
机构
[1] Sanofi Pasteur,
[2] Sanofi Singapore,undefined
[3] South Beach Tower,undefined
[4] Sanofi Pasteur,undefined
来源
关键词
Japanese encephalitis; Live-attenuated Japanese encephalitis chimeric virus vaccine; Safety; Vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:589 / 598
页数:9
相关论文
共 26 条
  • [1] Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev(R)) in South Korea, 2015-2019
    Kim, Hee Soo
    Oh, Yongho
    Korejwo, Joanna
    Castells, Valerie Bosch
    Yang, Kuhyun
    [J]. INFECTIOUS DISEASES AND THERAPY, 2020, 9 (03) : 589 - 598
  • [2] Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China
    Wang, Yali
    Dong, Duo
    Cheng, Gang
    Zuo, Shuyan
    Liu, Dawei
    Du, Xiaoxi
    [J]. VACCINE, 2014, 32 (44) : 5875 - 5879
  • [3] Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV®) in Taiwan, 2017-18
    Ma, Hsuan-Yin
    Lai, Chung-Chih
    Chiu, Nan-Chang
    Lee, Ping-Ing
    [J]. VACCINE, 2020, 38 (33) : 5219 - 5222
  • [4] Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children
    Chokephaibulkit, K.
    Houillon, G.
    Feroldi, E.
    Bouckenooghe, A.
    [J]. EXPERT REVIEW OF VACCINES, 2016, 15 (02) : 153 - 166
  • [5] Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013
    Wu Wendi
    Liu Dawei
    Li Keli
    Nuorti, J. Pekka
    Nohynek, Hanna M.
    Xu Disha
    Ye Jiakai
    Zheng Jingshan
    Wang Huaqing
    [J]. VACCINE, 2017, 35 (29) : 3666 - 3671
  • [6] Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012
    Liu, Yu
    Lin, Hualiang
    Zhu, Qi
    Wu, Chenggang
    Zhao, Zhanjie
    Zheng, Huizhen
    [J]. VACCINE, 2014, 32 (15) : 1768 - 1773
  • [7] Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States
    Takahashi, H
    Pool, V
    Tsai, TF
    Chen, RT
    [J]. VACCINE, 2000, 18 (26) : 2963 - 2969
  • [8] Post-Marketing Surveillance of Hepatitis A Virus Vaccine (AvaximA® 160U) in South Korea from 2011 to 2015
    Kim, HeeSoo
    Oh, Yongho
    Thollot, Yael
    Bravo, Catherine
    [J]. INFECTIOUS DISEASES AND THERAPY, 2019, 8 (01) : 105 - 112
  • [9] Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015
    HeeSoo Kim
    Yongho Oh
    Yael Thollot
    Catherine Bravo
    [J]. Infectious Diseases and Therapy, 2019, 8 : 105 - 112
  • [10] Allergic adverse events following immunization: Data from post-marketing surveillance in Apulia region (South of Italy)
    Stefanizzi, Pasquale
    Ferorelli, Davide
    Scazzi, Francesco Livio
    Di Lorenzo, Antonio
    Martinelli, Andrea
    Trinchera, Chiara
    Moscara, Lorenza
    Miniello, Enrico
    Di Bona, Danilo
    Tafuri, Silvio
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14